Cytochrome p450 1B1 (239-248)

Cytochrome p450 1B1 (239-248) is a synthetic peptide fragment derived from the human cytochrome P450 1B1 enzyme, which is a member of the cytochrome P450 superfamily involved in oxidative metabolism of a wide range of endogenous and xenobiotic compounds. As a well-defined peptide corresponding to amino acids 239 to 248 of the parent protein, it serves as a valuable tool in biochemical research focused on enzyme structure, function, and immunological recognition. The sequence's relevance stems from its association with key catalytic and substrate recognition domains, making it of particular interest for studies investigating the mechanistic and regulatory aspects of P450 enzymes.

Epitope mapping: The peptide is frequently utilized in epitope mapping studies to delineate antibody-binding regions within cytochrome P450 1B1. By employing this defined sequence, researchers can identify linear epitopes that are recognized by monoclonal or polyclonal antibodies, thereby facilitating the development of highly specific immunoassays and diagnostic reagents. Such mapping aids in understanding immune responses to P450 1B1 and supports the generation of targeted detection tools for use in research and analytical applications.

Enzyme structure-function analysis: As a segment of the P450 1B1 protein, this peptide is instrumental in probing the structural determinants underlying enzyme activity and substrate specificity. Incorporating the peptide into structural studies, such as NMR or crystallographic analyses, allows researchers to investigate local secondary structure, protein-protein interactions, or conformational changes relevant to the enzyme's catalytic function. These insights contribute to a deeper understanding of P450-mediated metabolic pathways and their regulation.

Peptide-based assay development: The defined nature of the 239-248 sequence enables its use as a standard or control in peptide-based assays, including enzyme-linked immunosorbent assays (ELISAs) and mass spectrometry-based quantification methods. By serving as a calibration or reference peptide, it supports the reliable measurement of P450 1B1 levels, activity, or immunoreactivity in various biological samples, enhancing assay reproducibility and data comparability across studies.

Immunogenicity assessment: The peptide provides a model antigen for evaluating immune recognition and potential immunogenic regions within cytochrome P450 1B1. Synthetic peptides such as this are essential for in vitro studies examining T-cell or B-cell responses, offering a controlled system for dissecting immune mechanisms at the molecular level. This application is particularly valuable in research exploring autoimmunity, allergy, or adverse immune reactions associated with P450 enzymes.

Proteomics and biomarker discovery: The unique sequence of the peptide makes it a useful tool in targeted proteomics workflows, where it can serve as a signature peptide for the identification and quantification of P450 1B1 in complex biological matrices. Its application in selected reaction monitoring (SRM) or multiple reaction monitoring (MRM) assays enables sensitive and specific detection, thereby supporting biomarker discovery efforts and advancing studies on the expression, regulation, and function of cytochrome P450 enzymes in health and disease.

1. Myotropic activity of allatostatins in tenebrionid beetles

2. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet